BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 17318881)

  • 1. Behavioral synergism between D(1) and D(2) dopamine receptors in mice does not depend on gap junctions.
    Nolan EB; Harrison LM; Lahoste GJ; Ruskin DN
    Synapse; 2007 May; 61(5):279-87. PubMed ID: 17318881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Behavioral effects of chronic apomorphine, and D-1/D-2 dopamine receptor activities in rats].
    Minematsu N
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1995 Jun; 15(3):247-52. PubMed ID: 7584718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conditioned locomotion induced by unilateral intrastriatal administration of apomorphine: D(2) receptor activation is critical but not the expression of the unconditioned response.
    Dias FR; Carey RJ; Carrera MP
    Brain Res; 2006 Apr; 1083(1):85-95. PubMed ID: 16530737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ontogeny of apomorphine-induced stereotypy and its D1 and D2 receptor mediation in rats depleted of dopamine as neonates.
    Abrams DR; Bruno JP
    Dev Psychobiol; 1992 Nov; 25(7):475-95. PubMed ID: 1459343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the intrastriatal administration of selective dopaminergic agonists on Fos expression in the rat brain.
    Blandini F; Fancellu R; Orzi F; Conti G; Greco R; Tassorelli C; Nappi G
    Neurol Sci; 2002 Sep; 23 Suppl 2():S57-8. PubMed ID: 12548342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term haloperidol treatment (but not risperidone) enhances addiction-related behaviors in mice: role of dopamine D2 receptors.
    Carvalho RC; Fukushiro DF; Helfer DC; Callegaro-Filho D; Trombin TF; Zanlorenci LH; Sanday L; Silva RH; Frussa-Filho R
    Addict Biol; 2009 Jul; 14(3):283-93. PubMed ID: 19298320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Ras homolog Rhes affects dopamine D1 and D2 receptor-mediated behavior in mice.
    Quintero GC; Spano D; Lahoste GJ; Harrison LM
    Neuroreport; 2008 Oct; 19(16):1563-6. PubMed ID: 18845937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Focused motor stereotypies do not require enhanced activation of neurons in striosomes.
    Glickstein SB; Schmauss C
    J Comp Neurol; 2004 Feb; 469(2):227-38. PubMed ID: 14694536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Link between dopamine D1 and D2 receptors in rat and human striatal tissues.
    Seeman P; Tallerico T
    Synapse; 2003 Mar; 47(4):250-4. PubMed ID: 12539197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repeated administration of a dopamine D1 receptor agonist reverses the increased proportions of striatal dopamine D1High and D2High receptors in methamphetamine-sensitized rats.
    Shuto T; Seeman P; Kuroiwa M; Nishi A
    Eur J Neurosci; 2008 May; 27(10):2551-7. PubMed ID: 18489579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotypic, ethologically based resolution of spontaneous and D(2)-like vs D(1)-like agonist-induced behavioural topography in mice with congenic D(3) dopamine receptor "knockout".
    McNamara FN; Clifford JJ; Tighe O; Kinsella A; Drago J; Fuchs S; Croke DT; Waddington JL
    Synapse; 2002 Oct; 46(1):19-31. PubMed ID: 12211095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine receptors in the anterior insular cortex modulate long-term nociception in the rat.
    Coffeen U; López-Avila A; Ortega-Legaspi JM; del Angel R; López-Muñoz FJ; Pellicer F
    Eur J Pain; 2008 Jul; 12(5):535-43. PubMed ID: 17936656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ethological resolution of behavioural topography and D1-like versus D2-like agonist responses in congenic D5 dopamine receptor mutants: identification of D5:D2-like interactions.
    O'Sullivan GJ; Kinsella A; Sibley DR; Tighe O; Croke DT; Waddington JL
    Synapse; 2005 Mar; 55(4):201-11. PubMed ID: 15668951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation by group I mGLU receptor activation and group III mGLU receptor blockade of locomotor responses induced by D1-like and D2-like receptor agonists in the nucleus accumbens.
    Rouillon C; Degoulet M; Chevallier K; Abraini JH; David HN
    Brain Res; 2008 Mar; 1198():44-54. PubMed ID: 18261716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blockade of globus pallidus adenosine A(2A) receptors displays antiparkinsonian activity in 6-hydroxydopamine-lesioned rats treated with D(1) or D(2) dopamine receptor agonists.
    Simola N; Fenu S; Baraldi PG; Tabrizi MA; Morelli M
    Synapse; 2008 May; 62(5):345-51. PubMed ID: 18297692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential electrophysiological properties of dopamine D1 and D2 receptor-containing striatal medium-sized spiny neurons.
    Cepeda C; André VM; Yamazaki I; Wu N; Kleiman-Weiner M; Levine MS
    Eur J Neurosci; 2008 Feb; 27(3):671-82. PubMed ID: 18279319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ethologically based resolution of D2-like dopamine receptor agonist-versus antagonist-induced behavioral topography in dopamine- and adenosine 3',5'-monophosphate-regulated phosphoprotein of 32 kDa "knockout" mutants congenic on the C57BL/6 genetic background.
    Nally RE; Kinsella A; Tighe O; Croke DT; Fienberg AA; Greengard P; Waddington JL
    J Pharmacol Exp Ther; 2004 Sep; 310(3):1281-7. PubMed ID: 15140917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenosine A1 receptor-mediated inhibition of dopamine release from rat striatal slices is modulated by D1 dopamine receptors.
    O'Neill C; Nolan BJ; Macari A; O'Boyle KM; O'Connor JJ
    Eur J Neurosci; 2007 Dec; 26(12):3421-8. PubMed ID: 18052983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of 12-chloroscoulerine enantiomers on animal behavior to dopamine receptors.
    Chen LJ; Zhou QT; Dong ZJ; Yu LP; Jin GZ
    Zhongguo Yao Li Xue Bao; 1999 Oct; 20(10):884-8. PubMed ID: 11270985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Behavioral pharmacological investigation and clinical consideration of the inhibitory potencies of psychotropic drugs against the D-1 and D-2 dopamine receptors].
    Kazawa T
    Yakubutsu Seishin Kodo; 1986 Sep; 6(3):327-37. PubMed ID: 2949452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.